PhD, Molecular Pharmacology
University of Wolverhampton, Wolverhampton, United Kingdom
MSc, Biomedical Sciences
Nottingham Trent University, Nottingham, United Kingdom
BPharm
Mangalore University, Konaje, India
Vijay D’Souza, PhD, is an Associate Director in the Market Access and Outcomes Strategy group at RTI-HS and is based in Cambridge, UK. In his current role, Vijay works on developing HEOR strategic plans, providing strategic and technical advisory support, value dossiers and literature reviews. He has over 7 years of experience in evidence synthesis and market access projects including primary research in pricing, reimbursement, and strategic market access. Vijay has experience in a broad range of therapy areas including lung diseases, oncology, ophthalmology, cardiovascular disorders, autoimmune diseases, rare genetic disorders, and medical devices. Vijay’s strategic market access experience includes testing target product profile, pricing assumptions, regulatory environments, horizon scanning and early access considerations. Vijay also has a background in respiratory research and translational clinical trials and has published in several peer reviewed journals.